Quick Answer
Genenta Science S.p.A. reported Stockholders Equity of $12.50 million for fiscal year 2024.
Genenta Science S.p.A. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $12.50M | -38.8% |
| 2023 | $20.43M | -34.4% |
| 2022 | $31.14M | -19.9% |
| 2021 | $38.86M | +156.5% |
| 2020 | $15.15M | -19.6% |
| 2019 | $18.85M | +137.7% |
| 2018 | $7.93M | — |
- Genenta Science S.p.A. showed a decrease of -38.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2024 period, Genenta Science S.p.A.’s stockholders equity has grown by 57.6% (from $7.93 million to $12.50 million).
- The most recent figure is from Genenta Science S.p.A.’s fiscal year 2024 report (Form 20-F), filed with the SEC on March 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: